Leukotriene receptor antagonists in asthma therapy

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 1 SUPPL., 2003, Pages

  Peters, Stephen P ^a   Hamid, Qutayba ^b   Moqbel, Redwan ^b   Sampson, Anthony ^b   Peters Golden, Marc ^b   Leff, Jon ^b   Pizzichini, Emilio ^b   Edelman, Jon ^b   Liu, Mark ^b   Bisgaard, Hans ^b   Henderson, Bill ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b Gibbon Building ^*

Author keywords

Asthma symptoms; Distal airways; Dyspnea; End points; Leukotriene receptor antagonists; Pulmonary function

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG FUNCTION; MEDIATOR RELEASE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0037252473     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.21     Document Type: Conference Paper

References (33)

1. RC Murphy S Hammarstrom B Samuelsson Leukotriene C: a slow-reacting substance from murine mastocytoma cells Proc Natl Acad Sci U S A 76 1979 4275 4279
2. PM O'Byrne E Israel JM Drazen Antileukotrienes in the treatment of asthma Ann Intern Med 127 1997 472 480
3. JM Drazen E Israel PM O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 1999 197 206
4. TF Reiss P Chervinsky RJ Dockhorn S Shingo B Seidenberg TB Edwards Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group Arch Intern Med 158 1998 1213 1220
5. K Malmstrom G Rodriguez-Gomez J Guerra C Villaran A Pineiro LX Wei Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast/Beclomethasone Study Group Ann Intern Med 130 1999 487 495
6. N Barnes LX Wei TF Reiss JA Leff S Shingo C Yu Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function Respir Med 95 2001 379 386
7. E Pizzichini JA Leff TF Reiss L Hendeles LP Boulet LX Wei Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial Eur Respir J 14 1999 12 18
8. H Bisgaard L Loland JA Oj NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast Am J Respir Crit Care Med 160 1999 1227 1231
9. AP Sampson DP Castling CP Green JF Price Persistent increase in plasma and urinary leukotrienes after acute asthma Arch Dis Child 73 1995 221 225
10. M Laviolette K Malmstrom S Lu P Chervinsky JC Pujet I Peszek Montelukast added to inhaled beclomethasone in treatment of asthma Am J Respir Crit Care Med 160 1999 1862 1868
11. 4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group Am J Respir Crit Care Med 150 1994 618 623
12. JE Fish JP Kemp RF Lockey M Glass LA Hanby CM Bonuccelli Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group Clin Ther 19 1997 675 690
13. RA Nathan JA Bernstein L Bielory CM Bonuccelli WJ Calhoun SP Galant Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction J Allergy Clin Immunol 102 1998 935 942
14. JC Virchow A Prasse I Naya L Summerton A Harris Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids Am J Respir Crit Care Med 162 2000 578 585
15. W Busse H Nelson J Wolfe C Kalberg SW Yancey KA Rickard Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma J Allergy Clin Immunol 103 1999 1075 1080
16. CG Lofdahl TF Reiss JA Leff E Israel MJ Noonan AF Finn Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients BMJ 319 1999 87 90
17. NC Barnes CJ Miller Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials Thorax 55 2000 478 483
18. ER Bleecker MJ Welch SF Weinstein C Kalberg M Johnson L Edwards Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma J Allergy Clin Immunol 105 2000 1123 1129
19. W Busse GD Raphael SP Galant C Kalberg S Goode-Sellers S Srebro Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial J Allergy Clin Immunol 107 2001 461 468
20. L Strauss R Hejal G Galan L Dixon ER McFadden Observations on the effects of aerosolized albuterol in acute asthma Am J Respir Crit Care Med 155 1997 454 458
21. ER McFadden R Hejal Asthma Lancet 345 1995 1215 1220
22. SJ Szefler RJ Martin TS King HA Boushey R Cherniack VM Chinchilli Significant variability in response to inhaled corticosteroids for persistent asthma J Allergy Clin Immunol 109 2002 410 418
23. RB Banzett JA Dempsey DE O'Donnell MZ Wamboldt Symptom perception and respiratory sensation in asthma Am J Respir Crit Care Med 162 2000 1178 1182
24. R Ottanelli E Rosi I Romagnoli M Grazzini L Stendardi R Duranti Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest 120 2001 770 777
25. M Griffin JW Weiss AG Leitch ER McFadden EJ Corey KF Austen Effects of leukotriene D on the airways in asthma N Engl J Med 308 1983 436 439
26. 4 in humans Am Rev Respir Dis 131 1985 368 372
27. MH Lavietes J Matta LA Tiersky BH Natelson L Bielory NS Cherniack The perception of dyspnea in patients with mild asthma Chest 120 2001 409 415
28. 2-agonist use? Respir Med 95 2001 319 323
29. JG Teeter ER Bleecker Relationship between airway obstruction and respiratory symptoms in adult asthmatics Chest 113 1998 272 277
30. EM Wagner MC Liu GG Weinmann S Permutt ER Bleecker Peripheral lung resistance in normal and asthmatic subjects Am Rev Respir Dis 141 1990 584 588
31. CG Irvin J Pak RJ Martin Airway-parenchyma uncoupling in nocturnal asthma Am J Respir Crit Care Med 161 2000 50 56
32. M Kraft RJ Martin S Wilson R Djukanovic ST Holgate Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma Am J Respir Crit Care Med 159 1999 228 234
33. JG Goldin DP Tashkin EC Kleerup LE Greaser UM Haywood JW Sayre Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography J Allergy Clin Immunol 104 1999 S258 S267